In a three-dimensional osteosarcoma model, the increased expression of several drug-resistance-related genes (Bcl2, Abcb1, Abcg2, Nanog, Sox2) was closely associated with heightened glutamine metabolism [32]. The gene discussed is BCL2; the disease is osteosarcoma.